Serum Levels of Insulin-like Growth Factor-1 and Insulin-like Growth Factor-1 Binding Proteins After Radical Prostatectomy
- 1 November 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (5) , 2249-2252
- https://doi.org/10.1016/s0022-5347(05)64365-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?The Lancet, 2000
- The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancerBJU International, 2000
- The Insulin-Like Growth Factor-Binding Protein (IGFBP) SuperfamilyEndocrine Reviews, 1999
- Insulin-Like Growth Factor-Binding Protein-1 and Prostate CancerJNCI Journal of the National Cancer Institute, 1999
- Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.JNCI Journal of the National Cancer Institute, 1998
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective StudyScience, 1998
- Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasiaBritish Journal of Cancer, 1997
- Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostateJournal of Clinical Endocrinology & Metabolism, 1996
- Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigenJournal of Clinical Endocrinology & Metabolism, 1993
- Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patientsJournal of Clinical Endocrinology & Metabolism, 1993